Screener
Theriva Biologics TOVX Q3 2025 earnings
Reported November 12, 2025 · Before market open
EPS-$0.45Miss by $0.07
EPS estimate-$0.38
Next report
Nov 17, 2026 (in 2 months)EPS estimate-$0.07
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Theriva Biologics report Q3 2025 earnings?
- Theriva Biologics (TOVX) reported Q3 2025 earnings on November 12, 2025 before market open.
- What were Theriva Biologics's Q3 2025 revenue and EPS?
- Theriva Biologics reported eps of $-0.45 for Q3 2025.
- Did Theriva Biologics beat estimates in Q3 2025?
- EPS missed the consensus estimate of $-0.38 by $0.07.
- How did Theriva Biologics's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 93.4% from $-6.81.
- Where can I find Theriva Biologics's Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001104659-25-109821) and the 10-Q periodic report (0001104659-25-109828) directly on SEC EDGAR. The filing index links above go to sec.gov.
